James N. Woody, Director, 10% Owner at OncoMed Pharmaceuticals Inc (OMED), bought 105,559 shares at $17.00 ($1.5M) on 2013-07-23, disclosed to the SEC on 2013-07-23.
Open-market purchase of $1.5M OMED by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 17,324 | $0 | 0.0% |
| 2 | $17.00 | 1,080 | $18K | 1.2% |
| 3 | $17.00 | 2,161 | $37K | 2.4% |
| 4 | $17.00 | 7,937 | $135K | 9.0% |
| 5 | $17.00 | 33,834 | $575K | 38.3% |
| 6 | $17.00 | 43,223 |
| $735K |
| 49.0% |
| Total | $14.21 avg | 105,559 | $1.5M | 100% |
| Filing → |
| ATNF | BUY | 2021-12-10 | $107K | — | Filing → |
| ATNF | BUY | 2020-11-12 | $3K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $1.8M | — | Filing → |